The Share

Novakand Pharma’s share has been traded on Nasdaq First North Premier up until April 13, 2026 with the short name NOVKAN and the ISIN code SE0003622265. The board is currently exploring options regarding a possible listing of the stock on a trading venue (stock exchange).

Dividend policy

The size of future possible dividends to holders of shares in Novakand Pharma depends on a number of factors, such as earnings, financial position, cash flow and working capital requirements. Only when long-term profitability can be predicted via the launch of products on the market will dividends to shareholders be possible. In the next few years, therefore, no dividend will be paid.

Insider information

Such cases are handled in accordance with the Swedish Companies Act (ABL) and Swedish law, and are adjudicated under the Swedish Penal Code.